Advertisement

Breast Cancer Stem Cells & Therapy Resistance

  • Phuc Van Pham

Part of the SpringerBriefs in Stem Cells book series (BRIEFSSTEM)

Table of contents

  1. Front Matter
    Pages i-xi
  2. Phuc Van Pham
    Pages 1-4
  3. Phuc Van Pham
    Pages 5-24
  4. Phuc Van Pham
    Pages 57-74
  5. Phuc Van Pham
    Pages 75-96
  6. Phuc Van Pham
    Pages 109-110
  7. Back Matter
    Pages 111-114

About this book

Introduction

This volume thoroughly examines breast cancer stem cells (BCSCs), from basic definitions to techniques for identifying, isolating, culturing, and targeting BCSCs for therapy; there is additional focus on pre-clinical and clinical results. The text begins with a discussion of breast cancer, focusing especially on the limitations of current therapies in its treatment. The subsequent chapters introduce and compare stem cells and cancer stem cells, describe properties and isolation techniques of BCSCs, and examine BCSC-targeting approaches. The text concludes with a discussion of controversy surrounding the BCSC hypothesis and of future research directions. Breast Cancer Stem Cells & Therapy Resistance, part of the SpringerBriefs in Stem Cells series, provides a succinct yet comprehensive overview of BCSCs for advanced students, graduate students and researchers as well as those working with breast cancer or stem cells in a clinical setting.

Keywords

BCSC-targeting therapy cancer cell culture cancer cell isolation cancer cell proliferation circulating tumor cells

Authors and affiliations

  • Phuc Van Pham
    • 1
  1. 1.Animal Physiology and BiotechnologyVietnam National University University of ScienceHo Chi Minh CityVietnam

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-319-22020-8
  • Copyright Information The author(s) 2015
  • Publisher Name Springer, Cham
  • eBook Packages Biomedical and Life Sciences
  • Print ISBN 978-3-319-22019-2
  • Online ISBN 978-3-319-22020-8
  • Series Print ISSN 2192-8118
  • Series Online ISSN 2192-8126
  • Buy this book on publisher's site
Industry Sectors
Pharma
Biotechnology